Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*

Offered as part of a routine CBC with differential test, the hematology-based solution is intended to alert emergency department clinicians to sepsis or the possibility of sepsis earlier than any other indicator BREA, Calif., June 25, 2018 -- (Healthca... Diagnostics, FDA Beckman Coulter, Early Sepsis Indicator, Sepsis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news